MFDS — authorised 23 July 1975
- Marketing authorisation holder: BRISTOL MYERS SQUIBB
- Status: likely_approved
🇰🇷 Estrace in South Korea
MFDS authorised Estrace on 23 July 1975
Marketing authorisation
Estrace in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Estrace approved in South Korea?
Yes. MFDS authorised it on 23 July 1975.
Who is the marketing authorisation holder for Estrace in South Korea?
BRISTOL MYERS SQUIBB holds the South Korean marketing authorisation.